HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,355,489 | -68.9% | 35,484 | -70.6% | 0.00% | -69.2% |
Q2 2023 | $4,360,249 | +1308.5% | 120,883 | +1391.3% | 0.01% | +1200.0% |
Q1 2023 | $309,568 | -92.5% | 8,106 | -91.6% | 0.00% | -94.4% |
Q4 2020 | $4,118,000 | -51.2% | 96,415 | -70.0% | 0.02% | -45.5% |
Q3 2020 | $8,434,000 | +162.8% | 320,946 | +168.1% | 0.03% | +106.2% |
Q2 2020 | $3,209,000 | +113.2% | 119,693 | +43.0% | 0.02% | +60.0% |
Q1 2020 | $1,505,000 | -81.7% | 83,683 | -82.0% | 0.01% | -63.0% |
Q4 2019 | $8,246,000 | -26.9% | 465,054 | -36.1% | 0.03% | -35.7% |
Q3 2019 | $11,287,000 | +10.8% | 727,733 | +22.7% | 0.04% | +13.5% |
Q2 2019 | $10,188,000 | -18.3% | 593,058 | -23.4% | 0.04% | -21.3% |
Q1 2019 | $12,471,000 | -34.3% | 774,578 | -40.3% | 0.05% | -44.0% |
Q4 2018 | $18,982,000 | -11.3% | 1,297,446 | +10.1% | 0.08% | +7.7% |
Q3 2018 | $21,405,000 | +85.3% | 1,178,052 | +72.1% | 0.08% | +62.5% |
Q2 2018 | $11,549,000 | +89.7% | 684,603 | +120.3% | 0.05% | +71.4% |
Q1 2018 | $6,089,000 | – | 310,798 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |